Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingObservational

N2004-05: Neuroblastoma Biology Study

NCT ID: NCT01587300Sponsor: New Approaches to Neuroblastoma Therapy ConsortiumLast updated: 2026-03-23

Summary

Medical scientists want to find better ways to treat neuroblastoma and to find ways to prevent the tumor from growing back. To do this, they need more information about the characteristics of neuroblastoma cells. Therefore, they want to study samples of neuroblastoma tissues and neuroblastoma and normal cells in the blood and bone marrow that may be related to the growth of neuroblastoma cells. Doctors and other medical scientists also want to find better ways to detect and measure neuroblastoma to improve the ability to follow the response of tumor cells to therapy.

Detailed description

The purposes of this study are: To establish a storage place or bank of samples of blood, bone marrow, and/or tumor, and molecular components isolated from these samples from children with neuroblastoma. The stored specimens will be shared with laboratory researchers studying high risk neuroblastoma. To collect clinical data (such as treatments received, date of diagnosis, tumor stage, etc) and radiology scans to provide this information as needed for the laboratory studies to be done on the specimens. To obtain neuroblastoma tumor cells from tumor tissue, bone marrow, and/or blood to use to start cell lines, or tumor cells that will keep growing in the laboratory. These cell lines will be shared with laboratory researchers studying high risk neuroblastoma.

Eligibility criteria

Sex: AllAge: 31 Days to 99 YearsHealthy volunteers: No
Inclusion Criteria: * Patients must be greater than or 31 days of age. * Patients must have had a diagnosis of high risk neuroblastoma either by histological verification of neuroblastoma and/or demonstration of tumor cells in the bone marrow with increased urinary catecholamines. * All patients with refractory or recurrent high risk neuroblastoma at NANT institutions are eligible regardless of disease status (including no measurable or evaluable tumor) as long as they undergo a disease evaluation and appropriate samples are submitted. * Additionally, all patients with high risk neuroblastoma without relapse treated at a NANT institution are eligible if undergoing a disease evaluation, as long as Children's Oncology Group specimens are prioritized. Exclusion Criteria: * There are no exclusion criteria on this study.

Study locations (16)

Children's Hospital Los Angeles

Los Angeles, California, 90027-0700

Recruiting
Araz Marachelian, MD · Contact

Lucille Salter Packer Children's Hospital, Stanford University

Palo Alto, California, 94305

Completed

UCSF Helen Diller Family Comprehensive Cancer Center

San Francisco, California, 94115

Recruiting
Kieuhoa Vo, MD · Contact

Children Hospital of Colorado

Aurora, Colorado, 80045

Recruiting
Margaret Macy, MD · Contact

AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus

Atlanta, Georgia, 30322

Recruiting
Kelly Goldsmith, MD · Contact

University of Chicago, Comer Children's Hospital

Chicago, Illinois, 60637

Recruiting
Ami Desai, MD · Contact

Children's Hospital Boston

Boston, Massachusetts, 02115

Recruiting
Suzanne Shusterman, MD · Contact

C.S Mott Children's Hospital

Ann Arbor, Michigan, 48109

Recruiting
Rajen Mody, MD · Contact

University of North Carolina

Chapel Hill, North Carolina, 27599

Completed

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, 45229-3039

Recruiting
Katherine Somers, MD · Contact

Nationwide Children's Hospital

Columbus, Ohio, 43205

Recruiting
Keri Streby, MD · Contact

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, 19104-4318

Recruiting
Yael Mosse, MD · Contact

St. Jude Children's Research Hospital

Memphis, Tennessee, 38105

Not Yet Recruiting
Sara Federico, MD · Contact

University of Texas Southwestern

Dallas, Texas, 75235

Not Yet Recruiting
Tanya Watt, MD · Contact

Cook Children's Medical Center - Fort Worth

Fort Worth, Texas, 76104

Recruiting
Chelsee Greer, DO · Contact

Seattle Children's Hospital

Seattle, Washington, 98105

Recruiting
Mark Fluchel, MD · Contact